<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.valueinvestingnews.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Value Investing News - CMCSA - Comments</title>
 <link>http://www.valueinvestingnews.com/stock-tickers/cmcsa</link>
 <description>Comments for &quot;CMCSA&quot;</description>
 <language>en</language>
<item>
 <title>I used to own PFE at a very</title>
 <link>http://www.valueinvestingnews.com/irving-kahn-adds-to-pfizer-inc-first-place-financial-corp-reduces-the-travelers-companies-in#comment-820</link>
 <description>&lt;p&gt;I used to own PFE at a very similar cost basis George, but patience and the threat of generics got the best of me.&lt;/p&gt;
</description>
 <pubDate>Sun, 29 Jul 2007 11:07:48 -0400</pubDate>
 <dc:creator>Nick</dc:creator>
 <guid isPermaLink="false">comment 820 at http://www.valueinvestingnews.com</guid>
</item>
<item>
 <title>It seems like a good buy but</title>
 <link>http://www.valueinvestingnews.com/irving-kahn-adds-to-pfizer-inc-first-place-financial-corp-reduces-the-travelers-companies-in#comment-819</link>
 <description>&lt;p&gt;It seems like a good buy but not being an expert on drugs I can&#039;t predict who&#039;s drugs are going to be successful in the future and what profits PFE will have. I can&#039;t have confidence in the pipeline. I have the same uncertainty with tech though drug companies have monopoly prices after all the capex :  )&lt;/p&gt;
</description>
 <pubDate>Sun, 29 Jul 2007 00:29:20 -0400</pubDate>
 <dc:creator>Mark Perkins</dc:creator>
 <guid isPermaLink="false">comment 819 at http://www.valueinvestingnews.com</guid>
</item>
<item>
 <title>I&#039;m glad to know I&#039;m not the</title>
 <link>http://www.valueinvestingnews.com/irving-kahn-adds-to-pfizer-inc-first-place-financial-corp-reduces-the-travelers-companies-in#comment-818</link>
 <description>&lt;p&gt;I&#039;m glad to know I&#039;m not the only value investor that owns Pfizer.  I got in &lt;a href=&quot;http://www.fatpitchfinancials.com/468/pfizer-purchase-details/&quot;&gt;PFE at $24.85&lt;/a&gt;.  That&#039;s even lower than Irving Kahn&#039;s entry point according to the article.&lt;/p&gt;
</description>
 <pubDate>Sat, 28 Jul 2007 22:50:16 -0400</pubDate>
 <dc:creator>George</dc:creator>
 <guid isPermaLink="false">comment 818 at http://www.valueinvestingnews.com</guid>
</item>
</channel>
</rss>
